Immune System Disorder Clinical Trial
Official title:
A Phase 1b/2 Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of Isatuximab (SAR650984) in Patients Awaiting Kidney Transplantation
Primary Objectives: - Phase 1: To characterize the safety and tolerability of isatuximab in kidney transplant candidates. - Phase 2: To evaluate the efficacy of isatuximab in desensitization of participants awaiting kidney transplantation. Secondary Objectives: - Phase 2: To characterize the safety profile of isatuximab in kidney transplant candidates. - To characterize the pharmacokinetic (PK) profile of isatuximab in kidney transplant candidates. - To evaluate the immunogenicity of isatuximab. - To assess the overall efficacy of isatuximab in desensitization of participants awaiting kidney transplantation.
The study had a screening period of up to 28 days, a treatment period of up to 12 weeks, a site visit FUP of up to 26 weeks, and an extended follow-up (FUP) until study cut-off. The study duration involved site visit per participant (i.e., screening, treatment, site visit FUP was approximately 42 weeks. The study duration included extended FUP per participant was approximately 97.7 weeks (depending on when the participant was enrolled). ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT04430972 -
Immune Responsiveness and Outcome After Aortic Valve Surgery (Measure)
|
||
| Not yet recruiting |
NCT04830046 -
Covid-19 Vaccine Responsiveness in MM and Waldenstrom
|
||
| Recruiting |
NCT04928963 -
Fighting Immunosenescence and Promoting Immunity by a Fasting-mimicking Diet Elderly.
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05507242 -
Effects of Blocking TSLP on Airway Inflammation and the Epithelial Immune-response to Exacerbation Triggers in Patients With COPD
|
Phase 2 | |
| Completed |
NCT03385850 -
The Th17/Treg Cells and IL-23/IL-17 Axis and Early Enteral Nutrition in Sepsis
|
N/A | |
| Completed |
NCT03744676 -
A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)
|
Phase 2 | |
| Recruiting |
NCT06141915 -
Aerobic Training and Diet Protocol on Immune System in Burn Patients.
|
N/A | |
| Recruiting |
NCT03908736 -
Thinking Zinc: a Study of Zinc Supplements on the Navajo Nation
|
N/A | |
| Completed |
NCT04386395 -
Immune Changes in Severe COVID-19 Pulmonary Infections
|
||
| Active, not recruiting |
NCT06060509 -
Study on the Effects of Wheat and Corn Germ Blend Oil on Antioxidation and Immune Regulation of Dyslipidemia Population
|
N/A | |
| Recruiting |
NCT04444609 -
PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort
|
||
| Recruiting |
NCT06314451 -
Cross-condition Validation of the Steroid PRO
|
||
| Completed |
NCT05000307 -
Co-Sér: Serological Analysis and Viral Neutralization in People With a Documented COVID-19 Infection
|
N/A | |
| Active, not recruiting |
NCT06107348 -
COVID-19 Post-Vaccination Observation
|
||
| Recruiting |
NCT05139706 -
Montreal Immune-Related Adverse Events (MIRAE) Study
|
||
| Withdrawn |
NCT05219890 -
Transcriptomics of Mononuclear Cells and Inflammatory Status of Obese Patients Treated With Omega-3 Fatty Acids
|
N/A | |
| Completed |
NCT03357939 -
Phase I Study of HLX3 vs Adalimumab in Chinese Healthy Subjects
|
Phase 1 | |
| Recruiting |
NCT05002023 -
PRINCE Study - Cohort Study of Healthy Pregnant Women Followed by the Assessment of Children´s Health and Immunity
|
||
| Recruiting |
NCT05266664 -
Preterm Immune System Development and Response to Immunization
|
||
| Active, not recruiting |
NCT04802044 -
COVID-19, Aging, and Cardiometabolic Risk Factors Study
|